Madrigal Pharmaceuticals Inc (MDGL) · Insider trading
What Madrigal Pharmaceuticals's directors, officers and largest holders bought and sold themselves, from the Form 4 each of them files with the SEC within two business days of a trade. Open-market purchases and sales first: those are the trades somebody chose to make at the market price.
Bought, 12 months
$0
0 insiders, 0 trades
Sold, 12 months
$81.48M
9 insiders, 81% under a plan
Net, 12 months
−$81.48M
bought less sold
Latest filing
2026-09-11
filings read to 2026-10-19
Who traded, two years
| Insider | Bought | Sold | Trades | Last trade | Holds after |
|---|---|---|---|---|---|
| Friedman Paul ADirector | – | $101.80M | 77 | 2026-01-09 | 210,204 |
| Baker JulianDirector | $61.92M | – | 54 | 2025-08-20 | – |
| Taub RebeccaDirector | – | $49.49M | 66 | 2026-03-06 | 452,213 |
| Bate KennethDirector | – | $18.81M | 26 | 2025-11-05 | 17,439 |
| Sibold William JohnDirector, President and CEO | – | $17.31M | 41 | 2026-09-11 | 202,907 |
| Levy Richard SDirector | – | $10.61M | 31 | 2026-05-22 | 27,657 |
| Craves Fred BDirector | – | $7.41M | 17 | 2025-03-13 | 355,867 |
| Waltermire Robert E.Senior VP, Chief Pharma Dev. | – | $5.39M | 13 | 2025-03-05 | 16,941 |
| Daly James MDirector | – | $5.38M | 3 | 2025-02-27 | 16,984 |
| Dier MardiEVP and CFO | – | $4.49M | 31 | 2026-03-06 | 13,826 |
| Huntsman CaroleChief Commercial Officer | – | $2.65M | 25 | 2026-03-06 | 12,692 |
| Kelley Shannon TGeneral Counsel | – | $1.54M | 14 | 2026-08-17 | 11,474 |
| Soergel DavidChief Medical Officer | – | $951,981 | 2 | 2026-06-01 | 10,033 |
Open-market purchases and sales
Newest first. “Plan” marks a trade made under a 10b5-1 plan set up in advance.
| Date | Insider | Trade | Shares | Price | Value | Holds after | Filing |
|---|---|---|---|---|---|---|---|
| 2026-09-11 | Sibold William JohnDirector, President and CEO | Saleplan | 60 | 533.09 | $31,985 | 202,907 | Form 4 |
| 2026-09-11 | Sibold William JohnDirector, President and CEO | Saleplan | 106 | 534.06 | $56,610 | 202,801 | Form 4 |
| 2026-09-11 | Sibold William JohnDirector, President and CEO | Saleplan | 218 | 535.94 | $116,835 | 202,583 | Form 4 |
| 2026-09-11 | Sibold William JohnDirector, President and CEO | Saleplan | 160 | 537.62 | $86,019 | 202,423 | Form 4 |
| 2026-09-11 | Sibold William JohnDirector, President and CEO | Saleplan | 687 | 540.59 | $371,385 | 201,736 | Form 4 |
| 2026-09-11 | Sibold William JohnDirector, President and CEO | Saleplan | 368 | 541.64 | $199,324 | 201,368 | Form 4 |
| 2026-09-11 | Sibold William JohnDirector, President and CEO | Saleplan | 1,202 | 542.60 | $652,205 | 200,166 | Form 4 |
| 2026-09-11 | Sibold William JohnDirector, President and CEO | Saleplan | 1,539 | 544.02 | $837,247 | 198,627 | Form 4 |
| 2026-09-11 | Sibold William JohnDirector, President and CEO | Saleplan | 761 | 544.83 | $414,616 | 197,866 | Form 4 |
| 2026-09-11 | Sibold William JohnDirector, President and CEO | Saleplan | 120 | 546.38 | $65,566 | 197,746 | Form 4 |
| 2026-09-09 | Sibold William JohnDirector, President and CEO | Saleplan | 131 | 527.88 | $69,152 | 209,198 | Form 4 |
| 2026-09-09 | Sibold William JohnDirector, President and CEO | Saleplan | 347 | 529.27 | $183,657 | 208,851 | Form 4 |
| 2026-09-09 | Sibold William JohnDirector, President and CEO | Saleplan | 522 | 530.23 | $276,780 | 208,329 | Form 4 |
| 2026-09-09 | Sibold William JohnDirector, President and CEO | Saleplan | 368 | 531.99 | $195,772 | 207,961 | Form 4 |
| 2026-09-09 | Sibold William JohnDirector, President and CEO | Saleplan | 512 | 533.09 | $272,942 | 207,449 | Form 4 |
| 2026-09-09 | Sibold William JohnDirector, President and CEO | Saleplan | 396 | 534.20 | $211,543 | 207,053 | Form 4 |
| 2026-09-09 | Sibold William JohnDirector, President and CEO | Saleplan | 644 | 535.27 | $344,714 | 206,409 | Form 4 |
| 2026-09-09 | Sibold William JohnDirector, President and CEO | Saleplan | 1,040 | 536.11 | $557,554 | 205,369 | Form 4 |
| 2026-09-09 | Sibold William JohnDirector, President and CEO | Saleplan | 640 | 537.17 | $343,789 | 204,729 | Form 4 |
| 2026-09-09 | Sibold William JohnDirector, President and CEO | Saleplan | 520 | 538.30 | $279,916 | 204,209 | Form 4 |
| 2026-09-09 | Sibold William JohnDirector, President and CEO | Saleplan | 215 | 539.03 | $115,891 | 203,994 | Form 4 |
| 2026-09-09 | Sibold William JohnDirector, President and CEO | Saleplan | 505 | 540.19 | $272,796 | 203,489 | Form 4 |
| 2026-09-09 | Sibold William JohnDirector, President and CEO | Saleplan | 362 | 541.65 | $196,077 | 203,127 | Form 4 |
| 2026-09-09 | Sibold William JohnDirector, President and CEO | Saleplan | 160 | 542.55 | $86,808 | 202,967 | Form 4 |
| 2026-08-17 | Kelley Shannon TGeneral Counsel | Sale | 664 | 514.97 | $341,940 | 11,474 | Form 4 |
| 2026-07-20 | Sibold William JohnDirector, President and CEO | Sale | 140 | 542.75 | $75,985 | 211,689 | Form 4 |
| 2026-07-20 | Sibold William JohnDirector, President and CEO | Sale | 110 | 543.79 | $59,817 | 211,579 | Form 4 |
| 2026-07-20 | Sibold William JohnDirector, President and CEO | Sale | 545 | 544.71 | $296,867 | 211,034 | Form 4 |
| 2026-07-20 | Sibold William JohnDirector, President and CEO | Sale | 275 | 545.71 | $150,070 | 210,759 | Form 4 |
| 2026-07-20 | Sibold William JohnDirector, President and CEO | Sale | 269 | 547.08 | $147,165 | 210,490 | Form 4 |
| 2026-07-20 | Sibold William JohnDirector, President and CEO | Sale | 680 | 547.70 | $372,436 | 209,810 | Form 4 |
| 2026-07-20 | Sibold William JohnDirector, President and CEO | Sale | 47 | 548.87 | $25,797 | 209,763 | Form 4 |
| 2026-07-20 | Sibold William JohnDirector, President and CEO | Sale | 153 | 550.01 | $84,152 | 209,610 | Form 4 |
| 2026-07-20 | Sibold William JohnDirector, President and CEO | Sale | 1 | 550.72 | $551 | 209,609 | Form 4 |
| 2026-07-20 | Sibold William JohnDirector, President and CEO | Sale | 280 | 555.05 | $155,414 | 209,329 | Form 4 |
| 2026-06-01 | Soergel DavidChief Medical Officer | Saleplan | 1,042 | 495.74 | $516,561 | 10,033 | Form 4 |
| 2026-05-22 | Levy Richard SDirector | Saleplan | 40 | 506.68 | $20,267 | 27,657 | Form 4 |
| 2026-05-22 | Levy Richard SDirector | Saleplan | 320 | 508.24 | $162,637 | 27,337 | Form 4 |
| 2026-05-22 | Levy Richard SDirector | Saleplan | 151 | 510.36 | $77,064 | 27,186 | Form 4 |
| 2026-05-22 | Levy Richard SDirector | Saleplan | 610 | 511.40 | $311,954 | 26,576 | Form 4 |
360 more
| 2026-05-22 | Levy Richard SDirector | Saleplan | 439 | 512.50 | $224,988 | 26,137 | Form 4 |
| 2026-05-22 | Levy Richard SDirector | Saleplan | 40 | 512.97 | $20,519 | 26,097 | Form 4 |
| 2026-05-22 | Levy Richard SDirector | Saleplan | 343 | 514.67 | $176,532 | 25,754 | Form 4 |
| 2026-05-22 | Levy Richard SDirector | Saleplan | 657 | 515.92 | $338,959 | 25,097 | Form 4 |
| 2026-05-22 | Levy Richard SDirector | Saleplan | 723 | 516.87 | $373,697 | 24,374 | Form 4 |
| 2026-05-22 | Levy Richard SDirector | Saleplan | 1,497 | 517.59 | $774,832 | 22,877 | Form 4 |
| 2026-05-22 | Levy Richard SDirector | Saleplan | 782 | 518.76 | $405,670 | 22,095 | Form 4 |
| 2026-05-22 | Levy Richard SDirector | Saleplan | 80 | 519.98 | $41,598 | 22,015 | Form 4 |
| 2026-05-18 | Soergel DavidChief Medical Officer | Sale | 844 | 515.90 | $435,420 | 11,075 | Form 4 |
| 2026-03-06 | Taub RebeccaDirector | Sale | 491 | 431.94 | $212,083 | 452,213 | Form 4 |
| 2026-03-06 | Huntsman CaroleChief Commercial Officer | Sale | 419 | 431.94 | $180,983 | 12,692 | Form 4 |
| 2026-03-06 | Kelley Shannon TGeneral Counsel | Sale | 360 | 431.94 | $155,498 | 12,138 | Form 4 |
| 2026-03-06 | Sibold William JohnDirector, President and CEO | Sale | 1,663 | 431.94 | $718,316 | 161,829 | Form 4 |
| 2026-03-06 | Dier MardiEVP and CFO | Saleplan | 646 | 431.94 | $279,033 | 13,826 | Form 4 |
| 2026-03-06 | Dier MardiEVP and CFO | Saleplan | 40 | 425.08 | $17,003 | 13,786 | Form 4 |
| 2026-03-06 | Dier MardiEVP and CFO | Saleplan | 420 | 426.86 | $179,281 | 13,366 | Form 4 |
| 2026-03-06 | Dier MardiEVP and CFO | Saleplan | 80 | 427.85 | $34,228 | 13,286 | Form 4 |
| 2026-03-06 | Dier MardiEVP and CFO | Saleplan | 160 | 429.00 | $68,640 | 13,126 | Form 4 |
| 2026-03-06 | Dier MardiEVP and CFO | Saleplan | 40 | 429.58 | $17,183 | 13,086 | Form 4 |
| 2026-03-06 | Dier MardiEVP and CFO | Saleplan | 120 | 430.90 | $51,708 | 12,966 | Form 4 |
| 2026-03-06 | Dier MardiEVP and CFO | Saleplan | 116 | 432.56 | $50,177 | 12,850 | Form 4 |
| 2026-03-06 | Dier MardiEVP and CFO | Saleplan | 160 | 434.20 | $69,472 | 12,690 | Form 4 |
| 2026-03-06 | Dier MardiEVP and CFO | Saleplan | 80 | 435.32 | $34,826 | 12,610 | Form 4 |
| 2026-03-06 | Dier MardiEVP and CFO | Saleplan | 80 | 436.69 | $34,935 | 12,530 | Form 4 |
| 2026-03-06 | Dier MardiEVP and CFO | Saleplan | 40 | 437.65 | $17,506 | 12,490 | Form 4 |
| 2026-03-02 | Dier MardiEVP and CFO | Sale | 1,183 | 427.21 | $505,389 | 9,257 | Form 4 |
| 2026-01-26 | Taub RebeccaDirector | Sale | 647 | 492.42 | $318,596 | 452,704 | Form 4 |
| 2026-01-26 | Sibold William JohnDirector, President and CEO | Sale | 1,577 | 492.42 | $776,546 | 148,497 | Form 4 |
| 2026-01-26 | Huntsman CaroleChief Commercial Officer | Saleplan | 340 | 492.42 | $167,423 | 9,692 | Form 4 |
| 2026-01-26 | Huntsman CaroleChief Commercial Officer | Saleplan | 570 | 494.59 | $281,916 | 9,122 | Form 4 |
| 2026-01-20 | Taub RebeccaDirector | Sale | 2,238 | 490.77 | $1.10M | 453,351 | Form 4 |
| 2026-01-20 | Kelley Shannon TGeneral Counsel | Saleplan | 263 | 490.77 | $129,073 | 8,910 | Form 4 |
| 2026-01-20 | Kelley Shannon TGeneral Counsel | Saleplan | 429 | 501.40 | $215,101 | 8,481 | Form 4 |
| 2026-01-09 | Taub RebeccaDirector | Saleplan | 960 | 512.02 | $491,539 | 473,039 | Form 4 |
| 2026-01-09 | Taub RebeccaDirector | Saleplan | 960 | 513.12 | $492,595 | 472,079 | Form 4 |
| 2026-01-09 | Taub RebeccaDirector | Saleplan | 937 | 514.63 | $482,208 | 471,142 | Form 4 |
| 2026-01-09 | Taub RebeccaDirector | Saleplan | 1,578 | 515.82 | $813,964 | 469,564 | Form 4 |
| 2026-01-09 | Taub RebeccaDirector | Saleplan | 521 | 516.81 | $269,258 | 469,043 | Form 4 |
| 2026-01-09 | Taub RebeccaDirector | Saleplan | 2,044 | 517.84 | $1.06M | 466,999 | Form 4 |
| 2026-01-09 | Taub RebeccaDirector | Saleplan | 970 | 518.67 | $503,110 | 466,029 | Form 4 |
| 2026-01-09 | Taub RebeccaDirector | Saleplan | 539 | 519.89 | $280,221 | 465,490 | Form 4 |
| 2026-01-09 | Taub RebeccaDirector | Saleplan | 440 | 521.11 | $229,288 | 465,050 | Form 4 |
| 2026-01-09 | Taub RebeccaDirector | Saleplan | 588 | 521.95 | $306,907 | 464,462 | Form 4 |
| 2026-01-09 | Taub RebeccaDirector | Saleplan | 732 | 522.98 | $382,821 | 463,730 | Form 4 |
| 2026-01-09 | Taub RebeccaDirector | Saleplan | 1,335 | 524.06 | $699,620 | 462,395 | Form 4 |
| 2026-01-09 | Taub RebeccaDirector | Saleplan | 1,489 | 525.12 | $781,904 | 460,906 | Form 4 |
| 2026-01-09 | Taub RebeccaDirector | Saleplan | 913 | 526.05 | $480,284 | 459,993 | Form 4 |
| 2026-01-09 | Taub RebeccaDirector | Saleplan | 1,135 | 526.95 | $598,088 | 458,858 | Form 4 |
| 2026-01-09 | Taub RebeccaDirector | Saleplan | 465 | 528.16 | $245,594 | 458,393 | Form 4 |
| 2026-01-09 | Taub RebeccaDirector | Saleplan | 554 | 529.28 | $293,221 | 457,839 | Form 4 |
| 2026-01-09 | Taub RebeccaDirector | Saleplan | 256 | 530.45 | $135,795 | 457,583 | Form 4 |
| 2026-01-09 | Taub RebeccaDirector | Saleplan | 30 | 531.05 | $15,931 | 457,553 | Form 4 |
| 2026-01-09 | Taub RebeccaDirector | Saleplan | 40 | 532.50 | $21,300 | 457,513 | Form 4 |
| 2026-01-09 | Taub RebeccaDirector | Saleplan | 271 | 534.18 | $144,763 | 457,242 | Form 4 |
| 2026-01-09 | Taub RebeccaDirector | Saleplan | 89 | 534.93 | $47,609 | 457,153 | Form 4 |
| 2026-01-09 | Taub RebeccaDirector | Saleplan | 299 | 535.80 | $160,204 | 456,854 | Form 4 |
| 2026-01-09 | Taub RebeccaDirector | Saleplan | 385 | 536.88 | $206,699 | 456,469 | Form 4 |
| 2026-01-09 | Taub RebeccaDirector | Saleplan | 40 | 537.84 | $21,514 | 456,429 | Form 4 |
| 2026-01-09 | Taub RebeccaDirector | Saleplan | 400 | 539.26 | $215,704 | 456,029 | Form 4 |
| 2026-01-09 | Taub RebeccaDirector | Saleplan | 40 | 540.26 | $21,610 | 455,989 | Form 4 |
| 2026-01-09 | Taub RebeccaDirector | Saleplan | 400 | 542.72 | $217,088 | 455,589 | Form 4 |
| 2026-01-09 | Taub RebeccaDirector | Saleplan | 40 | 545.79 | $21,832 | 455,789 | Form 4 |
| 2026-01-09 | Taub RebeccaDirector | Saleplan | 200 | 551.24 | $110,248 | 455,589 | Form 4 |
| 2026-01-09 | Friedman Paul ADirector | Saleplan | 1,480 | 511.98 | $757,730 | 210,204 | Form 4 |
| 2026-01-09 | Friedman Paul ADirector | Saleplan | 1,094 | 513.11 | $561,342 | 209,110 | Form 4 |
| 2026-01-09 | Friedman Paul ADirector | Saleplan | 1,345 | 514.68 | $692,245 | 207,765 | Form 4 |
| 2026-01-09 | Friedman Paul ADirector | Saleplan | 1,996 | 515.81 | $1.03M | 205,769 | Form 4 |
| 2026-01-09 | Friedman Paul ADirector | Saleplan | 766 | 516.84 | $395,899 | 205,003 | Form 4 |
| 2026-01-09 | Friedman Paul ADirector | Saleplan | 2,450 | 517.86 | $1.27M | 202,553 | Form 4 |
| 2026-01-09 | Friedman Paul ADirector | Saleplan | 1,363 | 518.68 | $706,961 | 201,190 | Form 4 |
| 2026-01-09 | Friedman Paul ADirector | Saleplan | 846 | 519.88 | $439,818 | 200,344 | Form 4 |
| 2026-01-09 | Friedman Paul ADirector | Saleplan | 681 | 521.03 | $354,821 | 199,663 | Form 4 |
| 2026-01-09 | Friedman Paul ADirector | Saleplan | 840 | 521.98 | $438,463 | 198,823 | Form 4 |
| 2026-01-09 | Friedman Paul ADirector | Saleplan | 970 | 523.00 | $507,310 | 197,853 | Form 4 |
| 2026-01-09 | Friedman Paul ADirector | Saleplan | 1,199 | 524.10 | $628,396 | 196,654 | Form 4 |
| 2026-01-09 | Friedman Paul ADirector | Saleplan | 2,432 | 525.05 | $1.28M | 194,222 | Form 4 |
| 2026-01-09 | Friedman Paul ADirector | Saleplan | 1,066 | 526.00 | $560,716 | 193,156 | Form 4 |
| 2026-01-09 | Friedman Paul ADirector | Saleplan | 1,560 | 526.97 | $822,073 | 191,596 | Form 4 |
| 2026-01-09 | Friedman Paul ADirector | Saleplan | 575 | 528.18 | $303,704 | 191,021 | Form 4 |
| 2026-01-09 | Friedman Paul ADirector | Saleplan | 691 | 529.17 | $365,656 | 190,330 | Form 4 |
| 2026-01-09 | Friedman Paul ADirector | Saleplan | 166 | 529.76 | $87,940 | 190,164 | Form 4 |
| 2026-01-09 | Friedman Paul ADirector | Saleplan | 280 | 530.69 | $148,593 | 189,884 | Form 4 |
| 2026-01-09 | Friedman Paul ADirector | Saleplan | 80 | 532.50 | $42,600 | 189,804 | Form 4 |
| 2026-01-09 | Friedman Paul ADirector | Saleplan | 332 | 534.16 | $177,341 | 189,472 | Form 4 |
| 2026-01-09 | Friedman Paul ADirector | Saleplan | 148 | 535.29 | $79,223 | 189,324 | Form 4 |
| 2026-01-09 | Friedman Paul ADirector | Saleplan | 473 | 536.02 | $253,537 | 188,851 | Form 4 |
| 2026-01-09 | Friedman Paul ADirector | Saleplan | 487 | 536.88 | $261,461 | 188,364 | Form 4 |
| 2026-01-09 | Friedman Paul ADirector | Saleplan | 80 | 537.85 | $43,028 | 188,284 | Form 4 |
| 2026-01-09 | Friedman Paul ADirector | Saleplan | 480 | 539.23 | $258,830 | 187,804 | Form 4 |
| 2026-01-09 | Friedman Paul ADirector | Saleplan | 600 | 540.36 | $324,216 | 187,204 | Form 4 |
| 2026-01-09 | Friedman Paul ADirector | Saleplan | 40 | 545.79 | $21,832 | 187,164 | Form 4 |
| 2026-01-09 | Friedman Paul ADirector | Saleplan | 280 | 551.24 | $154,347 | 187,164 | Form 4 |
| 2025-12-10 | Taub RebeccaDirector | Saleplan | 491 | 547.76 | $268,950 | 479,203 | Form 4 |
| 2025-12-10 | Taub RebeccaDirector | Saleplan | 369 | 548.56 | $202,419 | 478,834 | Form 4 |
| 2025-12-10 | Taub RebeccaDirector | Saleplan | 486 | 550.07 | $267,334 | 478,348 | Form 4 |
| 2025-12-10 | Taub RebeccaDirector | Saleplan | 4,723 | 550.99 | $2.60M | 473,625 | Form 4 |
| 2025-12-10 | Taub RebeccaDirector | Saleplan | 4,410 | 551.85 | $2.43M | 469,215 | Form 4 |
| 2025-12-10 | Taub RebeccaDirector | Saleplan | 3,857 | 552.81 | $2.13M | 465,358 | Form 4 |
| 2025-12-10 | Taub RebeccaDirector | Saleplan | 3,087 | 553.88 | $1.71M | 462,271 | Form 4 |
| 2025-12-10 | Taub RebeccaDirector | Saleplan | 1,027 | 554.84 | $569,821 | 461,244 | Form 4 |
| 2025-12-10 | Taub RebeccaDirector | Saleplan | 200 | 555.39 | $111,078 | 461,044 | Form 4 |
| 2025-12-10 | Friedman Paul ADirector | Saleplan | 624 | 547.75 | $341,796 | 211,340 | Form 4 |
| 2025-12-10 | Friedman Paul ADirector | Saleplan | 535 | 548.51 | $293,453 | 210,805 | Form 4 |
| 2025-12-10 | Friedman Paul ADirector | Saleplan | 409 | 549.99 | $224,946 | 210,396 | Form 4 |
| 2025-12-10 | Friedman Paul ADirector | Saleplan | 4,316 | 550.93 | $2.38M | 206,080 | Form 4 |
| 2025-12-10 | Friedman Paul ADirector | Saleplan | 7,193 | 551.67 | $3.97M | 198,887 | Form 4 |
| 2025-12-10 | Friedman Paul ADirector | Saleplan | 5,533 | 552.74 | $3.06M | 193,354 | Form 4 |
| 2025-12-10 | Friedman Paul ADirector | Saleplan | 5,001 | 553.83 | $2.77M | 188,353 | Form 4 |
| 2025-12-10 | Friedman Paul ADirector | Saleplan | 1,029 | 555.00 | $571,095 | 187,324 | Form 4 |
| 2025-12-10 | Friedman Paul ADirector | Saleplan | 160 | 555.39 | $88,862 | 187,164 | Form 4 |
| 2025-12-04 | Sibold William JohnDirector, President and CEO | Sale | 2,400 | 575.34 | $1.38M | 150,074 | Form 4 |
| 2025-12-02 | Dier MardiEVP and CFO | Saleplan | 320 | 570.39 | $182,525 | 14,293 | Form 4 |
| 2025-12-02 | Dier MardiEVP and CFO | Saleplan | 410 | 571.99 | $234,516 | 13,883 | Form 4 |
| 2025-12-02 | Dier MardiEVP and CFO | Saleplan | 354 | 573.02 | $202,849 | 13,529 | Form 4 |
| 2025-12-02 | Dier MardiEVP and CFO | Saleplan | 717 | 574.00 | $411,558 | 12,812 | Form 4 |
| 2025-12-02 | Dier MardiEVP and CFO | Saleplan | 120 | 574.95 | $68,994 | 12,692 | Form 4 |
| 2025-12-02 | Dier MardiEVP and CFO | Saleplan | 240 | 576.15 | $138,276 | 12,452 | Form 4 |
| 2025-12-02 | Dier MardiEVP and CFO | Saleplan | 320 | 577.81 | $184,899 | 12,132 | Form 4 |
| 2025-12-02 | Dier MardiEVP and CFO | Saleplan | 258 | 578.83 | $149,338 | 11,874 | Form 4 |
| 2025-12-02 | Dier MardiEVP and CFO | Saleplan | 480 | 579.85 | $278,328 | 11,394 | Form 4 |
| 2025-12-02 | Dier MardiEVP and CFO | Saleplan | 240 | 585.44 | $140,506 | 11,154 | Form 4 |
| 2025-12-02 | Dier MardiEVP and CFO | Saleplan | 240 | 587.85 | $141,084 | 10,914 | Form 4 |
| 2025-12-02 | Dier MardiEVP and CFO | Saleplan | 160 | 589.65 | $94,344 | 10,754 | Form 4 |
| 2025-12-02 | Dier MardiEVP and CFO | Saleplan | 160 | 590.37 | $94,459 | 10,594 | Form 4 |
| 2025-12-02 | Dier MardiEVP and CFO | Saleplan | 74 | 595.20 | $44,045 | 10,520 | Form 4 |
| 2025-12-02 | Dier MardiEVP and CFO | Saleplan | 80 | 596.19 | $47,695 | 10,440 | Form 4 |
| 2025-11-21 | Huntsman CaroleChief Commercial Officer | Saleplan | 894 | 550.97 | $492,567 | 11,096 | Form 4 |
| 2025-11-21 | Huntsman CaroleChief Commercial Officer | Saleplan | 144 | 547.27 | $78,807 | 10,952 | Form 4 |
| 2025-11-21 | Huntsman CaroleChief Commercial Officer | Saleplan | 120 | 548.71 | $65,845 | 10,832 | Form 4 |
| 2025-11-21 | Huntsman CaroleChief Commercial Officer | Saleplan | 40 | 549.34 | $21,974 | 10,792 | Form 4 |
| 2025-11-21 | Huntsman CaroleChief Commercial Officer | Saleplan | 200 | 552.38 | $110,476 | 10,592 | Form 4 |
| 2025-11-21 | Huntsman CaroleChief Commercial Officer | Saleplan | 40 | 553.23 | $22,129 | 10,552 | Form 4 |
| 2025-11-21 | Huntsman CaroleChief Commercial Officer | Saleplan | 120 | 556.04 | $66,725 | 10,432 | Form 4 |
| 2025-11-21 | Huntsman CaroleChief Commercial Officer | Saleplan | 200 | 559.60 | $111,920 | 10,232 | Form 4 |
| 2025-11-21 | Huntsman CaroleChief Commercial Officer | Saleplan | 80 | 560.62 | $44,850 | 10,152 | Form 4 |
| 2025-11-21 | Huntsman CaroleChief Commercial Officer | Saleplan | 40 | 563.21 | $22,528 | 10,112 | Form 4 |
| 2025-11-21 | Huntsman CaroleChief Commercial Officer | Saleplan | 80 | 564.57 | $45,166 | 10,032 | Form 4 |
| 2025-11-13 | Levy Richard SDirector | Saleplan | 146 | 514.67 | $75,142 | 29,551 | Form 4 |
| 2025-11-13 | Levy Richard SDirector | Saleplan | 919 | 515.64 | $473,873 | 28,632 | Form 4 |
| 2025-11-13 | Levy Richard SDirector | Saleplan | 645 | 517.51 | $333,794 | 27,987 | Form 4 |
| 2025-11-13 | Levy Richard SDirector | Saleplan | 835 | 518.53 | $432,973 | 27,152 | Form 4 |
| 2025-11-13 | Levy Richard SDirector | Saleplan | 1,355 | 519.67 | $704,153 | 25,797 | Form 4 |
| 2025-11-13 | Levy Richard SDirector | Saleplan | 308 | 520.68 | $160,369 | 25,489 | Form 4 |
| 2025-11-13 | Levy Richard SDirector | Saleplan | 1,094 | 521.79 | $570,838 | 24,395 | Form 4 |
| 2025-11-13 | Levy Richard SDirector | Saleplan | 1,434 | 522.70 | $749,552 | 22,961 | Form 4 |
| 2025-11-13 | Levy Richard SDirector | Saleplan | 811 | 523.66 | $424,688 | 22,150 | Form 4 |
| 2025-11-13 | Levy Richard SDirector | Saleplan | 153 | 524.49 | $80,247 | 21,997 | Form 4 |
| 2025-11-13 | Levy Richard SDirector | Saleplan | 120 | 526.68 | $63,202 | 21,877 | Form 4 |
| 2025-11-13 | Levy Richard SDirector | Saleplan | 200 | 527.85 | $105,570 | 21,677 | Form 4 |
| 2025-11-13 | Levy Richard SDirector | Saleplan | 440 | 528.60 | $232,584 | 21,237 | Form 4 |
| 2025-11-13 | Levy Richard SDirector | Saleplan | 40 | 530.21 | $21,208 | 21,197 | Form 4 |
| 2025-11-05 | Bate KennethDirector | Sale | 1,763 | 480.24 | $846,663 | 17,439 | Form 4 |
| 2025-11-05 | Bate KennethDirector | Sale | 3,259 | 481.13 | $1.57M | 14,180 | Form 4 |
| 2025-11-05 | Bate KennethDirector | Sale | 1,284 | 482.41 | $619,414 | 12,896 | Form 4 |
| 2025-11-05 | Bate KennethDirector | Sale | 2,069 | 483.41 | $1.00M | 10,827 | Form 4 |
| 2025-11-05 | Bate KennethDirector | Sale | 1,931 | 484.78 | $936,110 | 8,896 | Form 4 |
| 2025-11-05 | Bate KennethDirector | Sale | 1,008 | 485.54 | $489,424 | 7,888 | Form 4 |
| 2025-11-05 | Bate KennethDirector | Sale | 827 | 486.73 | $402,526 | 7,061 | Form 4 |
| 2025-11-05 | Bate KennethDirector | Sale | 2,775 | 487.49 | $1.35M | 4,286 | Form 4 |
| 2025-11-05 | Bate KennethDirector | Sale | 696 | 489.09 | $340,407 | 3,590 | Form 4 |
| 2025-11-05 | Bate KennethDirector | Sale | 933 | 489.95 | $457,123 | 2,657 | Form 4 |
| 2025-11-05 | Bate KennethDirector | Sale | 30 | 490.98 | $14,729 | 2,627 | Form 4 |
| 2025-09-09 | Sibold William JohnDirector, President and CEO | Sale | 7,279 | 445.63 | $3.24M | 102,474 | Form 4 |
| 2025-08-21 | Sibold William JohnDirector, President and CEO | Saleplan | 6,485 | 400.03 | $2.59M | 110,884 | Form 4 |
| 2025-08-21 | Sibold William JohnDirector, President and CEO | Saleplan | 1,131 | 401.00 | $453,531 | 109,753 | Form 4 |
| 2025-08-20 | Baker JulianDirectorwith Baker Felix, Baker Bros. Advisors LP, Baker Brothers Life Sciences LP, 667, L.P., Baker Bros. Advisors (gp) LLC | Buyindirect | 480 | 380.44 | $182,611 | 198,240 | Form 4 |
| 2025-08-20 | Baker JulianDirectorwith Baker Felix, Baker Bros. Advisors LP, Baker Brothers Life Sciences LP, 667, L.P., Baker Bros. Advisors (gp) LLC | Buyindirect | 5,209 | 380.44 | $1.98M | 1,898,329 | Form 4 |
| 2025-08-20 | Baker JulianDirectorwith Baker Felix, Baker Bros. Advisors LP, Baker Brothers Life Sciences LP, 667, L.P., Baker Bros. Advisors (gp) LLC | Buyindirect | 176 | 380.78 | $67,017 | 198,416 | Form 4 |
| 2025-08-20 | Baker JulianDirectorwith Baker Felix, Baker Bros. Advisors LP, Baker Brothers Life Sciences LP, 667, L.P., Baker Bros. Advisors (gp) LLC | Buyindirect | 1,919 | 380.78 | $730,717 | 1,900,248 | Form 4 |
| 2025-08-20 | Baker JulianDirectorwith Baker Felix, Baker Bros. Advisors LP, Baker Brothers Life Sciences LP, 667, L.P., Baker Bros. Advisors (gp) LLC | Buyindirect | 873 | 381.12 | $332,718 | 199,289 | Form 4 |
| 2025-08-20 | Baker JulianDirectorwith Baker Felix, Baker Bros. Advisors LP, Baker Brothers Life Sciences LP, 667, L.P., Baker Bros. Advisors (gp) LLC | Buyindirect | 9,477 | 381.12 | $3.61M | 1,909,725 | Form 4 |
| 2025-08-20 | Baker JulianDirectorwith Baker Felix, Baker Bros. Advisors LP, Baker Brothers Life Sciences LP, 667, L.P., Baker Bros. Advisors (gp) LLC | Buyindirect | 105 | 382.29 | $40,140 | 199,394 | Form 4 |
| 2025-08-20 | Baker JulianDirectorwith Baker Felix, Baker Bros. Advisors LP, Baker Brothers Life Sciences LP, 667, L.P., Baker Bros. Advisors (gp) LLC | Buyindirect | 1,136 | 382.29 | $434,281 | 1,910,861 | Form 4 |
| 2025-08-20 | Baker JulianDirectorwith Baker Felix, Baker Bros. Advisors LP, Baker Brothers Life Sciences LP, 667, L.P., Baker Bros. Advisors (gp) LLC | Buyindirect | 262 | 382.82 | $100,299 | 199,656 | Form 4 |
| 2025-08-20 | Baker JulianDirectorwith Baker Felix, Baker Bros. Advisors LP, Baker Brothers Life Sciences LP, 667, L.P., Baker Bros. Advisors (gp) LLC | Buyindirect | 2,838 | 382.82 | $1.09M | 1,913,699 | Form 4 |
| 2025-08-20 | Baker JulianDirectorwith Baker Felix, Baker Bros. Advisors LP, Baker Brothers Life Sciences LP, 667, L.P., Baker Bros. Advisors (gp) LLC | Buyindirect | 373 | 383.79 | $143,154 | 200,029 | Form 4 |
| 2025-08-20 | Baker JulianDirectorwith Baker Felix, Baker Bros. Advisors LP, Baker Brothers Life Sciences LP, 667, L.P., Baker Bros. Advisors (gp) LLC | Buyindirect | 4,049 | 383.79 | $1.55M | 1,917,748 | Form 4 |
| 2025-08-20 | Baker JulianDirectorwith Baker Felix, Baker Bros. Advisors LP, Baker Brothers Life Sciences LP, 667, L.P., Baker Bros. Advisors (gp) LLC | Buyindirect | 1,248 | 385.06 | $480,555 | 201,277 | Form 4 |
| 2025-08-20 | Baker JulianDirectorwith Baker Felix, Baker Bros. Advisors LP, Baker Brothers Life Sciences LP, 667, L.P., Baker Bros. Advisors (gp) LLC | Buyindirect | 13,545 | 385.06 | $5.22M | 1,931,293 | Form 4 |
| 2025-08-20 | Baker JulianDirectorwith Baker Felix, Baker Bros. Advisors LP, Baker Brothers Life Sciences LP, 667, L.P., Baker Bros. Advisors (gp) LLC | Buyindirect | 409 | 387.07 | $158,312 | 201,686 | Form 4 |
| 2025-08-20 | Baker JulianDirectorwith Baker Felix, Baker Bros. Advisors LP, Baker Brothers Life Sciences LP, 667, L.P., Baker Bros. Advisors (gp) LLC | Buyindirect | 4,441 | 387.07 | $1.72M | 1,935,734 | Form 4 |
| 2025-08-20 | Baker JulianDirectorwith Baker Felix, Baker Bros. Advisors LP, Baker Brothers Life Sciences LP, 667, L.P., Baker Bros. Advisors (gp) LLC | Buyindirect | 34 | 389.00 | $13,226 | 201,720 | Form 4 |
| 2025-08-20 | Baker JulianDirectorwith Baker Felix, Baker Bros. Advisors LP, Baker Brothers Life Sciences LP, 667, L.P., Baker Bros. Advisors (gp) LLC | Buyindirect | 366 | 389.00 | $142,374 | 1,936,100 | Form 4 |
| 2025-08-20 | Baker JulianDirectorwith Baker Felix, Baker Bros. Advisors LP, Baker Brothers Life Sciences LP, 667, L.P., Baker Bros. Advisors (gp) LLC | Buyindirect | 231 | 389.89 | $90,065 | 201,951 | Form 4 |
| 2025-08-20 | Baker JulianDirectorwith Baker Felix, Baker Bros. Advisors LP, Baker Brothers Life Sciences LP, 667, L.P., Baker Bros. Advisors (gp) LLC | Buyindirect | 2,506 | 389.89 | $977,064 | 1,938,606 | Form 4 |
| 2025-08-20 | Baker JulianDirectorwith Baker Felix, Baker Bros. Advisors LP, Baker Brothers Life Sciences LP, 667, L.P., Baker Bros. Advisors (gp) LLC | Buyindirect | 862 | 392.24 | $338,111 | 202,813 | Form 4 |
| 2025-08-20 | Baker JulianDirectorwith Baker Felix, Baker Bros. Advisors LP, Baker Brothers Life Sciences LP, 667, L.P., Baker Bros. Advisors (gp) LLC | Buyindirect | 9,362 | 392.24 | $3.67M | 1,947,968 | Form 4 |
| 2025-08-18 | Baker JulianDirectorwith Baker Felix, Baker Bros. Advisors LP, Baker Brothers Life Sciences LP, 667, L.P., Baker Bros. Advisors (gp) LLC | Buyindirect | 177 | 353.88 | $62,637 | 189,014 | Form 4 |
| 2025-08-18 | Baker JulianDirectorwith Baker Felix, Baker Bros. Advisors LP, Baker Brothers Life Sciences LP, 667, L.P., Baker Bros. Advisors (gp) LLC | Buyindirect | 1,923 | 353.88 | $680,511 | 1,798,184 | Form 4 |
| 2025-08-18 | Baker JulianDirectorwith Baker Felix, Baker Bros. Advisors LP, Baker Brothers Life Sciences LP, 667, L.P., Baker Bros. Advisors (gp) LLC | Buyindirect | 84 | 355.00 | $29,820 | 189,098 | Form 4 |
| 2025-08-18 | Baker JulianDirectorwith Baker Felix, Baker Bros. Advisors LP, Baker Brothers Life Sciences LP, 667, L.P., Baker Bros. Advisors (gp) LLC | Buyindirect | 916 | 355.00 | $325,180 | 1,799,100 | Form 4 |
| 2025-08-18 | Baker JulianDirectorwith Baker Felix, Baker Bros. Advisors LP, Baker Brothers Life Sciences LP, 667, L.P., Baker Bros. Advisors (gp) LLC | Buyindirect | 767 | 357.02 | $273,834 | 189,865 | Form 4 |
| 2025-08-18 | Baker JulianDirectorwith Baker Felix, Baker Bros. Advisors LP, Baker Brothers Life Sciences LP, 667, L.P., Baker Bros. Advisors (gp) LLC | Buyindirect | 8,328 | 357.02 | $2.97M | 1,807,428 | Form 4 |
| 2025-08-18 | Baker JulianDirectorwith Baker Felix, Baker Bros. Advisors LP, Baker Brothers Life Sciences LP, 667, L.P., Baker Bros. Advisors (gp) LLC | Buyindirect | 228 | 358.21 | $81,672 | 190,093 | Form 4 |
| 2025-08-18 | Baker JulianDirectorwith Baker Felix, Baker Bros. Advisors LP, Baker Brothers Life Sciences LP, 667, L.P., Baker Bros. Advisors (gp) LLC | Buyindirect | 2,472 | 358.21 | $885,495 | 1,809,900 | Form 4 |
| 2025-08-18 | Baker JulianDirectorwith Baker Felix, Baker Bros. Advisors LP, Baker Brothers Life Sciences LP, 667, L.P., Baker Bros. Advisors (gp) LLC | Buyindirect | 784 | 359.39 | $281,762 | 190,877 | Form 4 |
| 2025-08-18 | Baker JulianDirectorwith Baker Felix, Baker Bros. Advisors LP, Baker Brothers Life Sciences LP, 667, L.P., Baker Bros. Advisors (gp) LLC | Buyindirect | 8,514 | 359.39 | $3.06M | 1,818,414 | Form 4 |
| 2025-08-18 | Baker JulianDirectorwith Baker Felix, Baker Bros. Advisors LP, Baker Brothers Life Sciences LP, 667, L.P., Baker Bros. Advisors (gp) LLC | Buyindirect | 502 | 361.37 | $181,408 | 191,379 | Form 4 |
| 2025-08-18 | Baker JulianDirectorwith Baker Felix, Baker Bros. Advisors LP, Baker Brothers Life Sciences LP, 667, L.P., Baker Bros. Advisors (gp) LLC | Buyindirect | 5,443 | 361.37 | $1.97M | 1,823,857 | Form 4 |
| 2025-08-18 | Baker JulianDirectorwith Baker Felix, Baker Bros. Advisors LP, Baker Brothers Life Sciences LP, 667, L.P., Baker Bros. Advisors (gp) LLC | Buyindirect | 515 | 362.39 | $186,631 | 191,894 | Form 4 |
| 2025-08-18 | Baker JulianDirectorwith Baker Felix, Baker Bros. Advisors LP, Baker Brothers Life Sciences LP, 667, L.P., Baker Bros. Advisors (gp) LLC | Buyindirect | 5,587 | 362.39 | $2.02M | 1,829,444 | Form 4 |
| 2025-08-18 | Baker JulianDirectorwith Baker Felix, Baker Bros. Advisors LP, Baker Brothers Life Sciences LP, 667, L.P., Baker Bros. Advisors (gp) LLC | Buyindirect | 255 | 363.75 | $92,756 | 192,149 | Form 4 |
| 2025-08-18 | Baker JulianDirectorwith Baker Felix, Baker Bros. Advisors LP, Baker Brothers Life Sciences LP, 667, L.P., Baker Bros. Advisors (gp) LLC | Buyindirect | 2,772 | 363.75 | $1.01M | 1,832,216 | Form 4 |
| 2025-08-18 | Baker JulianDirectorwith Baker Felix, Baker Bros. Advisors LP, Baker Brothers Life Sciences LP, 667, L.P., Baker Bros. Advisors (gp) LLC | Buyindirect | 211 | 366.30 | $77,289 | 192,360 | Form 4 |
| 2025-08-18 | Baker JulianDirectorwith Baker Felix, Baker Bros. Advisors LP, Baker Brothers Life Sciences LP, 667, L.P., Baker Bros. Advisors (gp) LLC | Buyindirect | 2,289 | 366.30 | $838,461 | 1,834,505 | Form 4 |
| 2025-08-18 | Baker JulianDirectorwith Baker Felix, Baker Bros. Advisors LP, Baker Brothers Life Sciences LP, 667, L.P., Baker Bros. Advisors (gp) LLC | Buyindirect | 442 | 367.77 | $162,554 | 192,802 | Form 4 |
| 2025-08-18 | Baker JulianDirectorwith Baker Felix, Baker Bros. Advisors LP, Baker Brothers Life Sciences LP, 667, L.P., Baker Bros. Advisors (gp) LLC | Buyindirect | 4,798 | 367.77 | $1.76M | 1,839,303 | Form 4 |
| 2025-08-18 | Baker JulianDirectorwith Baker Felix, Baker Bros. Advisors LP, Baker Brothers Life Sciences LP, 667, L.P., Baker Bros. Advisors (gp) LLC | Buyindirect | 131 | 368.84 | $48,318 | 192,933 | Form 4 |
| 2025-08-18 | Baker JulianDirectorwith Baker Felix, Baker Bros. Advisors LP, Baker Brothers Life Sciences LP, 667, L.P., Baker Bros. Advisors (gp) LLC | Buyindirect | 1,419 | 368.84 | $523,384 | 1,840,722 | Form 4 |
| 2025-08-18 | Baker JulianDirectorwith Baker Felix, Baker Bros. Advisors LP, Baker Brothers Life Sciences LP, 667, L.P., Baker Bros. Advisors (gp) LLC | Buyindirect | 253 | 369.34 | $93,443 | 193,186 | Form 4 |
| 2025-08-18 | Baker JulianDirectorwith Baker Felix, Baker Bros. Advisors LP, Baker Brothers Life Sciences LP, 667, L.P., Baker Bros. Advisors (gp) LLC | Buyindirect | 2,747 | 369.34 | $1.01M | 1,843,469 | Form 4 |
| 2025-08-18 | Baker JulianDirectorwith Baker Felix, Baker Bros. Advisors LP, Baker Brothers Life Sciences LP, 667, L.P., Baker Bros. Advisors (gp) LLC | Buyindirect | 506 | 371.01 | $187,731 | 193,692 | Form 4 |
| 2025-08-18 | Baker JulianDirectorwith Baker Felix, Baker Bros. Advisors LP, Baker Brothers Life Sciences LP, 667, L.P., Baker Bros. Advisors (gp) LLC | Buyindirect | 5,494 | 371.01 | $2.04M | 1,848,963 | Form 4 |
| 2025-08-18 | Baker JulianDirectorwith Baker Felix, Baker Bros. Advisors LP, Baker Brothers Life Sciences LP, 667, L.P., Baker Bros. Advisors (gp) LLC | Buyindirect | 933 | 372.16 | $347,225 | 194,625 | Form 4 |
| 2025-08-18 | Baker JulianDirectorwith Baker Felix, Baker Bros. Advisors LP, Baker Brothers Life Sciences LP, 667, L.P., Baker Bros. Advisors (gp) LLC | Buyindirect | 10,128 | 372.16 | $3.77M | 1,859,091 | Form 4 |
| 2025-08-18 | Baker JulianDirectorwith Baker Felix, Baker Bros. Advisors LP, Baker Brothers Life Sciences LP, 667, L.P., Baker Bros. Advisors (gp) LLC | Buyindirect | 2,460 | 372.87 | $917,260 | 197,085 | Form 4 |
| 2025-08-18 | Baker JulianDirectorwith Baker Felix, Baker Bros. Advisors LP, Baker Brothers Life Sciences LP, 667, L.P., Baker Bros. Advisors (gp) LLC | Buyindirect | 26,704 | 372.87 | $9.96M | 1,885,795 | Form 4 |
| 2025-08-18 | Baker JulianDirectorwith Baker Felix, Baker Bros. Advisors LP, Baker Brothers Life Sciences LP, 667, L.P., Baker Bros. Advisors (gp) LLC | Buyindirect | 675 | 374.43 | $252,740 | 197,760 | Form 4 |
| 2025-08-18 | Baker JulianDirectorwith Baker Felix, Baker Bros. Advisors LP, Baker Brothers Life Sciences LP, 667, L.P., Baker Bros. Advisors (gp) LLC | Buyindirect | 7,325 | 374.43 | $2.74M | 1,893,120 | Form 4 |
| 2025-08-18 | Kelley Shannon TGeneral Counsel | Saleplan | 458 | 358.66 | $164,266 | 10,019 | Form 4 |
| 2025-08-18 | Kelley Shannon TGeneral Counsel | Saleplan | 126 | 369.64 | $46,575 | 9,893 | Form 4 |
| 2025-08-18 | Kelley Shannon TGeneral Counsel | Saleplan | 84 | 370.06 | $31,085 | 9,809 | Form 4 |
| 2025-08-18 | Kelley Shannon TGeneral Counsel | Saleplan | 84 | 371.35 | $31,193 | 9,725 | Form 4 |
| 2025-08-18 | Kelley Shannon TGeneral Counsel | Saleplan | 252 | 372.44 | $93,855 | 9,473 | Form 4 |
| 2025-08-18 | Kelley Shannon TGeneral Counsel | Saleplan | 68 | 374.13 | $25,441 | 9,405 | Form 4 |
| 2025-08-18 | Kelley Shannon TGeneral Counsel | Saleplan | 190 | 375.75 | $71,392 | 9,215 | Form 4 |
| 2025-08-18 | Kelley Shannon TGeneral Counsel | Saleplan | 42 | 376.62 | $15,818 | 9,173 | Form 4 |
| 2025-08-15 | Bate KennethDirector | Sale | 2,317 | 363.41 | $842,021 | 10,310 | Form 4 |
| 2025-08-15 | Bate KennethDirector | Sale | 2,516 | 364.24 | $916,428 | 7,794 | Form 4 |
| 2025-08-15 | Bate KennethDirector | Sale | 2,567 | 365.33 | $937,802 | 5,227 | Form 4 |
| 2025-08-15 | Bate KennethDirector | Sale | 600 | 366.14 | $219,684 | 4,627 | Form 4 |
| 2025-08-15 | Bate KennethDirector | Sale | 1,104 | 367.63 | $405,864 | 3,523 | Form 4 |
| 2025-08-15 | Bate KennethDirector | Sale | 896 | 368.56 | $330,230 | 2,627 | Form 4 |
| 2025-08-13 | Friedman Paul ADirector | Saleplan | 1,600 | 358.23 | $573,168 | 314,736 | Form 4 |
| 2025-08-13 | Friedman Paul ADirector | Saleplan | 455 | 359.31 | $163,486 | 314,281 | Form 4 |
| 2025-08-13 | Friedman Paul ADirector | Saleplan | 3,153 | 360.27 | $1.14M | 311,128 | Form 4 |
| 2025-08-13 | Friedman Paul ADirector | Saleplan | 1,754 | 361.13 | $633,422 | 309,374 | Form 4 |
| 2025-08-13 | Friedman Paul ADirector | Saleplan | 1,439 | 362.29 | $521,335 | 307,935 | Form 4 |
| 2025-08-13 | Friedman Paul ADirector | Saleplan | 2,591 | 363.08 | $940,740 | 305,344 | Form 4 |
| 2025-08-13 | Friedman Paul ADirector | Saleplan | 3,529 | 364.02 | $1.28M | 301,815 | Form 4 |
| 2025-08-13 | Friedman Paul ADirector | Saleplan | 1,716 | 365.19 | $626,666 | 300,099 | Form 4 |
| 2025-08-13 | Friedman Paul ADirector | Saleplan | 3,152 | 366.22 | $1.15M | 296,947 | Form 4 |
| 2025-08-13 | Friedman Paul ADirector | Saleplan | 7,119 | 367.31 | $2.61M | 289,828 | Form 4 |
| 2025-08-13 | Friedman Paul ADirector | Saleplan | 6,788 | 368.34 | $2.50M | 283,040 | Form 4 |
| 2025-08-13 | Friedman Paul ADirector | Saleplan | 7,992 | 369.44 | $2.95M | 275,048 | Form 4 |
| 2025-08-13 | Friedman Paul ADirector | Saleplan | 7,877 | 370.44 | $2.92M | 267,171 | Form 4 |
| 2025-08-13 | Friedman Paul ADirector | Saleplan | 22,710 | 371.53 | $8.44M | 244,461 | Form 4 |
| 2025-08-13 | Friedman Paul ADirector | Saleplan | 28,976 | 372.39 | $10.79M | 215,485 | Form 4 |
| 2025-08-13 | Friedman Paul ADirector | Saleplan | 24,166 | 373.35 | $9.02M | 191,319 | Form 4 |
| 2025-08-13 | Friedman Paul ADirector | Saleplan | 4,155 | 374.38 | $1.56M | 187,164 | Form 4 |
| 2025-08-12 | Friedman Paul ADirector | Saleplan | 3,303 | 350.93 | $1.16M | 227,466 | Form 4 |
| 2025-08-12 | Friedman Paul ADirector | Saleplan | 3,202 | 351.59 | $1.13M | 224,264 | Form 4 |
| 2025-08-12 | Friedman Paul ADirector | Saleplan | 1,382 | 352.61 | $487,307 | 222,882 | Form 4 |
| 2025-08-12 | Friedman Paul ADirector | Saleplan | 4,768 | 354.06 | $1.69M | 218,114 | Form 4 |
| 2025-08-12 | Friedman Paul ADirector | Saleplan | 6,546 | 355.00 | $2.32M | 211,568 | Form 4 |
| 2025-08-12 | Friedman Paul ADirector | Saleplan | 5,244 | 355.97 | $1.87M | 206,324 | Form 4 |
| 2025-08-12 | Friedman Paul ADirector | Saleplan | 5,094 | 356.94 | $1.82M | 201,230 | Form 4 |
| 2025-08-12 | Friedman Paul ADirector | Saleplan | 8,434 | 357.93 | $3.02M | 192,796 | Form 4 |
| 2025-08-12 | Friedman Paul ADirector | Saleplan | 5,032 | 358.83 | $1.81M | 187,764 | Form 4 |
| 2025-08-12 | Friedman Paul ADirector | Saleplan | 600 | 359.81 | $215,886 | 187,164 | Form 4 |
| 2025-08-12 | Taub RebeccaDirector | Saleplan | 3,580 | 350.87 | $1.26M | 500,727 | Form 4 |
| 2025-08-12 | Taub RebeccaDirector | Saleplan | 2,870 | 351.60 | $1.01M | 497,857 | Form 4 |
| 2025-08-12 | Taub RebeccaDirector | Saleplan | 1,175 | 352.45 | $414,129 | 496,682 | Form 4 |
| 2025-08-12 | Taub RebeccaDirector | Saleplan | 4,587 | 354.04 | $1.62M | 492,095 | Form 4 |
| 2025-08-12 | Taub RebeccaDirector | Saleplan | 6,479 | 354.97 | $2.30M | 485,616 | Form 4 |
| 2025-08-12 | Taub RebeccaDirector | Saleplan | 5,752 | 355.95 | $2.05M | 479,864 | Form 4 |
| 2025-08-12 | Taub RebeccaDirector | Saleplan | 4,864 | 356.88 | $1.74M | 475,000 | Form 4 |
| 2025-08-12 | Taub RebeccaDirector | Saleplan | 6,715 | 357.85 | $2.40M | 468,285 | Form 4 |
| 2025-08-12 | Taub RebeccaDirector | Saleplan | 6,541 | 358.81 | $2.35M | 461,744 | Form 4 |
| 2025-08-12 | Taub RebeccaDirector | Saleplan | 700 | 359.71 | $251,797 | 461,044 | Form 4 |
| 2025-08-11 | Friedman Paul ADirector | Saleplan | 2,903 | 350.19 | $1.02M | 187,464 | Form 4 |
| 2025-08-11 | Friedman Paul ADirector | Saleplan | 300 | 351.04 | $105,312 | 187,164 | Form 4 |
| 2025-08-11 | Taub RebeccaDirector | Saleplan | 2,980 | 350.18 | $1.04M | 461,264 | Form 4 |
| 2025-08-11 | Taub RebeccaDirector | Saleplan | 220 | 351.02 | $77,224 | 461,044 | Form 4 |
| 2025-07-18 | Friedman Paul ADirector | Saleplan | 1,400 | 350.03 | $490,042 | 187,164 | Form 4 |
| 2025-07-18 | Taub RebeccaDirector | Saleplan | 1,000 | 350.01 | $350,010 | 461,044 | Form 4 |
| 2025-07-17 | Taub RebeccaDirector | Saleplan | 2,057 | 350.09 | $720,135 | 461,644 | Form 4 |
| 2025-07-17 | Taub RebeccaDirector | Saleplan | 600 | 351.50 | $210,900 | 461,044 | Form 4 |
| 2025-07-17 | Friedman Paul ADirector | Saleplan | 2,000 | 350.10 | $700,200 | 187,864 | Form 4 |
| 2025-07-17 | Friedman Paul ADirector | Saleplan | 700 | 351.57 | $246,099 | 187,164 | Form 4 |
| 2025-07-16 | Taub RebeccaDirector | Saleplan | 6,000 | 350.19 | $2.10M | 481,488 | Form 4 |
| 2025-07-16 | Taub RebeccaDirector | Saleplan | 1,897 | 351.37 | $666,549 | 479,591 | Form 4 |
| 2025-07-16 | Taub RebeccaDirector | Saleplan | 2,357 | 352.64 | $831,172 | 477,234 | Form 4 |
| 2025-07-16 | Taub RebeccaDirector | Saleplan | 2,569 | 353.82 | $908,964 | 474,665 | Form 4 |
| 2025-07-16 | Taub RebeccaDirector | Saleplan | 5,800 | 354.61 | $2.06M | 468,865 | Form 4 |
| 2025-07-16 | Taub RebeccaDirector | Saleplan | 6,441 | 355.61 | $2.29M | 462,424 | Form 4 |
| 2025-07-16 | Taub RebeccaDirector | Saleplan | 1,380 | 356.52 | $491,998 | 461,044 | Form 4 |
| 2025-07-16 | Friedman Paul ADirector | Saleplan | 5,541 | 350.17 | $1.94M | 207,799 | Form 4 |
| 2025-07-16 | Friedman Paul ADirector | Saleplan | 2,371 | 351.38 | $833,122 | 205,428 | Form 4 |
| 2025-07-16 | Friedman Paul ADirector | Saleplan | 2,110 | 352.67 | $744,134 | 203,318 | Form 4 |
| 2025-07-16 | Friedman Paul ADirector | Saleplan | 2,319 | 353.82 | $820,509 | 200,999 | Form 4 |
| 2025-07-16 | Friedman Paul ADirector | Saleplan | 6,851 | 354.65 | $2.43M | 194,148 | Form 4 |
| 2025-07-16 | Friedman Paul ADirector | Saleplan | 5,784 | 355.61 | $2.06M | 188,364 | Form 4 |
| 2025-07-16 | Friedman Paul ADirector | Saleplan | 1,200 | 356.62 | $427,944 | 187,164 | Form 4 |
| 2025-03-13 | Craves Fred BDirector | Sale | 1,951 | 322.45 | $629,100 | 355,867 | Form 4 |
| 2025-03-13 | Craves Fred BDirector | Sale | 1,649 | 323.47 | $533,402 | 354,218 | Form 4 |
| 2025-03-13 | Craves Fred BDirector | Sale | 900 | 324.69 | $292,221 | 353,318 | Form 4 |
| 2025-03-13 | Craves Fred BDirector | Sale | 800 | 325.63 | $260,504 | 352,518 | Form 4 |
| 2025-03-13 | Craves Fred BDirector | Sale | 1,000 | 327.63 | $327,630 | 351,518 | Form 4 |
| 2025-03-13 | Craves Fred BDirector | Sale | 400 | 328.68 | $131,472 | 351,118 | Form 4 |
| 2025-03-13 | Craves Fred BDirector | Sale | 967 | 329.86 | $318,975 | 350,151 | Form 4 |
| 2025-03-13 | Craves Fred BDirector | Sale | 75 | 330.23 | $24,767 | 350,076 | Form 4 |
| 2025-03-12 | Craves Fred BDirector | Sale | 1,587 | 330.54 | $524,567 | 356,217 | Form 4 |
| 2025-03-12 | Craves Fred BDirector | Sale | 2,759 | 331.36 | $914,222 | 353,458 | Form 4 |
| 2025-03-12 | Craves Fred BDirector | Sale | 2,382 | 332.38 | $791,729 | 351,076 | Form 4 |
| 2025-03-12 | Craves Fred BDirector | Sale | 800 | 333.66 | $266,928 | 350,276 | Form 4 |
| 2025-03-12 | Craves Fred BDirector | Sale | 200 | 334.97 | $66,994 | 350,076 | Form 4 |
| 2025-03-10 | Dier MardiSVP and CFO | Saleplan | 258 | 323.04 | $83,344 | 10,440 | Form 4 |
| 2025-03-05 | Waltermire Robert E.Senior VP, Chief Pharma Dev. | Sale | 900 | 335.15 | $301,635 | 16,941 | Form 4 |
| 2025-03-05 | Waltermire Robert E.Senior VP, Chief Pharma Dev. | Sale | 1,777 | 336.78 | $598,458 | 15,164 | Form 4 |
| 2025-03-05 | Waltermire Robert E.Senior VP, Chief Pharma Dev. | Sale | 1,146 | 338.09 | $387,451 | 14,018 | Form 4 |
| 2025-03-05 | Waltermire Robert E.Senior VP, Chief Pharma Dev. | Sale | 400 | 339.68 | $135,872 | 13,618 | Form 4 |
| 2025-03-05 | Waltermire Robert E.Senior VP, Chief Pharma Dev. | Sale | 1,657 | 340.75 | $564,623 | 11,961 | Form 4 |
| 2025-03-05 | Waltermire Robert E.Senior VP, Chief Pharma Dev. | Sale | 1,043 | 341.84 | $356,539 | 10,918 | Form 4 |
| 2025-03-05 | Waltermire Robert E.Senior VP, Chief Pharma Dev. | Sale | 1,077 | 342.90 | $369,303 | 9,841 | Form 4 |
| 2025-03-05 | Waltermire Robert E.Senior VP, Chief Pharma Dev. | Sale | 4,701 | 343.85 | $1.62M | 5,140 | Form 4 |
| 2025-03-05 | Waltermire Robert E.Senior VP, Chief Pharma Dev. | Sale | 1,412 | 344.76 | $486,801 | 3,728 | Form 4 |
| 2025-03-03 | Huntsman CaroleChief Commercial Officer | Saleplan | 71 | 313.08 | $22,229 | 10,367 | Form 4 |
| 2025-03-03 | Huntsman CaroleChief Commercial Officer | Saleplan | 200 | 314.74 | $62,948 | 10,167 | Form 4 |
| 2025-03-03 | Huntsman CaroleChief Commercial Officer | Saleplan | 300 | 320.21 | $96,063 | 9,867 | Form 4 |
| 2025-03-03 | Huntsman CaroleChief Commercial Officer | Saleplan | 200 | 323.65 | $64,730 | 9,667 | Form 4 |
| 2025-03-03 | Huntsman CaroleChief Commercial Officer | Saleplan | 200 | 324.59 | $64,918 | 9,467 | Form 4 |
| 2025-03-03 | Huntsman CaroleChief Commercial Officer | Saleplan | 100 | 326.34 | $32,634 | 9,367 | Form 4 |
| 2025-03-03 | Huntsman CaroleChief Commercial Officer | Saleplan | 100 | 327.49 | $32,749 | 9,267 | Form 4 |
| 2025-03-03 | Huntsman CaroleChief Commercial Officer | Saleplan | 100 | 329.64 | $32,964 | 9,167 | Form 4 |
| 2025-03-03 | Huntsman CaroleChief Commercial Officer | Saleplan | 563 | 335.00 | $188,605 | 8,604 | Form 4 |
| 2025-03-03 | Dier MardiSVP and CFO | Saleplan | 1,187 | 325.89 | $386,831 | 7,688 | Form 4 |
| 2025-03-03 | Dier MardiSVP and CFO | Saleplan | 774 | 323.54 | $250,420 | 6,914 | Form 4 |
| 2025-03-03 | Kelley Shannon TGeneral Counsel | Saleplan | 415 | 335.00 | $139,025 | 7,290 | Form 4 |
| 2025-02-28 | Waltermire Robert E.Senior VP, Chief Pharma Dev. | Sale | 1,052 | 340.99 | $358,721 | 3,903 | Form 4 |
| 2025-02-28 | Waltermire Robert E.Senior VP, Chief Pharma Dev. | Sale | 175 | 341.55 | $59,771 | 3,728 | Form 4 |
| 2025-02-27 | Bate KennethDirector | Sale | 100 | 351.01 | $35,101 | 21,812 | Form 4 |
| 2025-02-27 | Bate KennethDirector | Sale | 500 | 351.99 | $175,995 | 21,312 | Form 4 |
| 2025-02-27 | Bate KennethDirector | Sale | 238 | 353.83 | $84,212 | 21,074 | Form 4 |
| 2025-02-27 | Bate KennethDirector | Sale | 8,545 | 355.08 | $3.03M | 12,529 | Form 4 |
| 2025-02-27 | Bate KennethDirector | Sale | 2,791 | 356.51 | $995,019 | 9,738 | Form 4 |
| 2025-02-27 | Bate KennethDirector | Sale | 2,038 | 357.27 | $728,116 | 7,700 | Form 4 |
| 2025-02-27 | Bate KennethDirector | Sale | 3,548 | 358.33 | $1.27M | 4,152 | Form 4 |
| 2025-02-27 | Bate KennethDirector | Sale | 2,024 | 359.21 | $727,041 | 2,128 | Form 4 |
| 2025-02-27 | Bate KennethDirector | Sale | 216 | 360.07 | $77,775 | 1,912 | Form 4 |
| 2025-02-27 | Daly James MDirector | Sale | 398 | 346.90 | $138,066 | 16,984 | Form 4 |
| 2025-02-27 | Daly James MDirector | Sale | 14,302 | 347.39 | $4.97M | 2,682 | Form 4 |
| 2025-02-27 | Daly James MDirector | Sale | 770 | 348.94 | $268,684 | 1,912 | Form 4 |
| 2025-01-24 | Waltermire Robert E.Senior VP, Chief Pharma Dev. | Sale | 103 | 335.24 | $34,530 | 4,955 | Form 4 |
| 2025-01-24 | Taub RebeccaDirector, Pres., R&D, and CMO | Sale | 648 | 335.24 | $217,236 | 456,662 | Form 4 |
| 2025-01-24 | Sibold William JohnDirector, President and CEO | Sale | 1,584 | 335.24 | $531,020 | 54,303 | Form 4 |
| 2025-01-24 | Huntsman CaroleChief Commercial Officer | Sale | 347 | 335.24 | $116,328 | 10,438 | Form 4 |
| 2025-01-17 | Taub RebeccaDirector, Pres., R&D, and CMO | Sale | 1,689 | 273.41 | $461,789 | 457,310 | Form 4 |
| 2025-01-17 | Waltermire Robert E.Senior VP, Chief Pharma Dev. | Sale | 442 | 273.41 | $120,847 | 5,058 | Form 4 |
| 2025-01-17 | Kelley Shannon TGeneral Counsel | Sale | 277 | 273.41 | $75,735 | 7,705 | Form 4 |
| 2024-12-03 | Craves Fred BDirector | Saleindirect | 3,080 | 315.21 | $970,847 | 11,520 | Form 4 |
| 2024-12-03 | Craves Fred BDirector | Saleindirect | 520 | 315.90 | $164,268 | 11,000 | Form 4 |
| 2024-11-25 | Craves Fred BDirector | Saleindirect | 2,200 | 350.08 | $770,176 | 15,800 | Form 4 |
| 2024-11-25 | Craves Fred BDirector | Saleindirect | 1,200 | 350.71 | $420,852 | 14,600 | Form 4 |
| 2024-11-21 | Huntsman CaroleChief Commercial Officer | Sale | 688 | 316.92 | $218,041 | 10,785 | Form 4 |
| 2024-11-07 | Levy Richard SDirector | Saleplan | 5,000 | 350.00 | $1.75M | 11,012 | Form 4 |
| 2024-11-01 | Levy Richard SDirector | Saleplan | 2,800 | 300.10 | $840,280 | 13,212 | Form 4 |
| 2024-11-01 | Levy Richard SDirector | Saleplan | 1,100 | 301.22 | $331,342 | 12,112 | Form 4 |
| 2024-11-01 | Levy Richard SDirector | Saleplan | 800 | 302.25 | $241,800 | 11,312 | Form 4 |
| 2024-11-01 | Levy Richard SDirector | Saleplan | 300 | 304.29 | $91,287 | 11,012 | Form 4 |
Grants, exercises and other transactions
Pay, tax and paperwork rather than a choice to trade at the market price. Two years.
42 × option exercise30 × grant or award1 × gift
Show them
| Date | Insider | What | Shares | Price | Holds after | Filing |
|---|---|---|---|---|---|---|
| 2026-08-15 | Reed John CDirector | Grant or award A | +647 | – | 647 | Form 4 |
| 2026-07-17 | Sibold William JohnDirector, President and CEO | Option exercise M | +50,000 | – | 211,829 | Form 4 |
| 2026-06-17 | Baker JulianDirector | Grant or award A | +908 | – | 203,721 | Form 4 |
| 2026-06-17 | Baker JulianDirector | Grant or award A | +908 | – | 1,948,876 | Form 4 |
| 2026-06-17 | Brennan Daniel J.Director | Grant or award A | +404 | – | 1,371 | Form 4 |
| 2026-06-17 | Daly James MDirector | Grant or award A | +454 | – | 3,081 | Form 4 |
| 2026-06-17 | Fouse Jacqualyn ADirector | Grant or award A | +454 | – | 1,551 | Form 4 |
| 2026-06-17 | Levy Richard SDirector | Grant or award A | +454 | – | 22,469 | Form 4 |
| 2026-06-17 | Taub RebeccaDirector | Grant or award A | +454 | – | 452,667 | Form 4 |
| 2026-03-04 | Soergel DavidChief Medical Officer | Grant or award A | +4,374 | – | 11,919 | Form 4 |
| 2026-03-04 | Huntsman CaroleChief Commercial Officer | Grant or award A | +3,989 | – | 13,111 | Form 4 |
| 2026-03-04 | Kelley Shannon TGeneral Counsel | Grant or award A | +4,017 | – | 12,498 | Form 4 |
| 2026-03-04 | Sibold William JohnDirector, President and CEO | Grant or award A | +14,995 | – | 163,492 | Form 4 |
| 2026-03-04 | Dier MardiEVP and CFO | Grant or award A | +5,215 | – | 14,472 | Form 4 |
| 2026-02-23 | Levy Richard SDirector | Option exercise M | +2,500 | 7.36 | 27,697 | Form 4 |
| 2026-01-26 | Levy Richard SDirector | Option exercise M | +4,000 | 16.46 | 25,197 | Form 4 |
| 2026-01-15 | Thakkar RitaChief Accounting Officer | Grant or award A | +2,398 | – | 2,398 | Form 4 |
| 2026-01-09 | Taub RebeccaDirector | Option exercise M | +18,410 | 15.80 | 473,999 | Form 4 |
| 2026-01-09 | Taub RebeccaDirector | Option exercise M | +240 | 15.80 | 455,829 | Form 4 |
| 2026-01-09 | Friedman Paul ADirector | Option exercise M | +24,520 | 15.80 | 211,684 | Form 4 |
| 2026-01-09 | Friedman Paul ADirector | Option exercise M | +280 | 15.80 | 187,444 | Form 4 |
| 2025-12-10 | Taub RebeccaDirector | Option exercise M | +18,650 | 15.80 | 479,694 | Form 4 |
| 2025-12-10 | Taub RebeccaDirector | Gift G | −5,455 | – | 455,589 | Form 4 |
| 2025-12-10 | Friedman Paul ADirector | Option exercise M | +24,800 | 15.80 | 211,964 | Form 4 |
| 2025-12-03 | Sibold William JohnDirector, President and CEO | Option exercise M | +50,000 | – | 152,474 | Form 4 |
| 2025-12-02 | Dier MardiEVP and CFO | Option exercise M | +4,173 | 251.63 | 14,613 | Form 4 |
| 2025-11-13 | Levy Richard SDirector | Option exercise M | +2,500 | 7.36 | 23,697 | Form 4 |
| 2025-11-13 | Levy Richard SDirector | Option exercise M | +6,000 | 16.46 | 29,697 | Form 4 |
| 2025-11-05 | Bate KennethDirector | Option exercise M | +5,470 | 9.45 | 8,097 | Form 4 |
| 2025-11-05 | Bate KennethDirector | Option exercise M | +10,000 | 303.79 | 18,097 | Form 4 |
| 2025-11-05 | Bate KennethDirector | Option exercise M | +1,105 | 280.04 | 19,202 | Form 4 |
| 2025-08-15 | Bate KennethDirector | Option exercise M | +10,000 | 16.46 | 12,627 | Form 4 |
| 2025-08-13 | Friedman Paul ADirector | Option exercise M | +129,172 | 9.45 | 316,336 | Form 4 |
| 2025-08-12 | Friedman Paul ADirector | Option exercise M | +43,605 | 9.45 | 230,769 | Form 4 |
| 2025-08-12 | Taub RebeccaDirector | Option exercise M | +43,263 | 9.45 | 504,307 | Form 4 |
| 2025-08-11 | Friedman Paul ADirector | Option exercise M | +3,203 | 9.45 | 190,367 | Form 4 |
| 2025-08-11 | Taub RebeccaDirector | Option exercise M | +3,200 | 9.45 | 464,244 | Form 4 |
| 2025-08-01 | Brennan Daniel J.Director | Grant or award A | +967 | – | 967 | Form 4 |
| 2025-07-18 | Friedman Paul ADirector | Option exercise M | +1,400 | 9.45 | 188,564 | Form 4 |
| 2025-07-18 | Taub RebeccaDirector | Option exercise M | +1,000 | 9.45 | 462,044 | Form 4 |
| 2025-07-17 | Taub RebeccaDirector | Option exercise M | +2,657 | 9.45 | 463,701 | Form 4 |
| 2025-07-17 | Friedman Paul ADirector | Option exercise M | +2,700 | 9.45 | 189,864 | Form 4 |
| 2025-07-16 | Taub RebeccaDirector | Option exercise M | +26,444 | 9.45 | 487,488 | Form 4 |
| 2025-07-16 | Friedman Paul ADirector | Option exercise M | +26,176 | 9.45 | 213,340 | Form 4 |
| 2025-06-20 | Baker JulianDirector | Grant or award A | +1,430 | – | 188,837 | Form 4 |
| 2025-06-20 | Baker JulianDirector | Grant or award A | +1,430 | – | 1,796,261 | Form 4 |
| 2025-06-20 | Friedman Paul ADirector | Grant or award A | +715 | – | 187,164 | Form 4 |
| 2025-06-20 | Daly James MDirector | Grant or award A | +715 | – | 2,627 | Form 4 |
| 2025-06-20 | Fouse Jacqualyn ADirector | Grant or award A | +203 | – | 1,097 | Form 4 |
| 2025-06-20 | Levy Richard SDirector | Grant or award A | +715 | – | 21,197 | Form 4 |
| 2025-06-20 | Bate KennethDirector | Grant or award A | +715 | – | 2,627 | Form 4 |
| 2025-05-15 | Soergel DavidChief Medical Officer | Grant or award A | +7,545 | – | 7,545 | Form 4 |
| 2025-04-10 | Levy Richard SDirector | Option exercise M | +9,470 | 65.06 | 20,482 | Form 4 |
| 2025-03-13 | Craves Fred BDirector | Option exercise M | +7,742 | 65.06 | 357,818 | Form 4 |
| 2025-03-12 | Craves Fred BDirector | Option exercise M | +1,728 | 65.06 | 351,804 | Form 4 |
| 2025-03-12 | Craves Fred BDirector | Option exercise M | +6,000 | 111.06 | 357,804 | Form 4 |
| 2025-03-10 | Fouse Jacqualyn ADirector | Grant or award A | +894 | – | 894 | Form 4 |
| 2025-03-05 | Huntsman CaroleChief Commercial Officer | Grant or award A | +3,386 | – | 11,990 | Form 4 |
| 2025-03-05 | Kelley Shannon TGeneral Counsel | Grant or award A | +3,187 | – | 10,477 | Form 4 |
| 2025-03-05 | Taub RebeccaDirector, Pres., R&D, and CMO | Grant or award A | +4,382 | – | 461,044 | Form 4 |
| 2025-03-05 | Waltermire Robert E.Senior VP, Chief Pharma Dev. | Option exercise M | +6,825 | 87.92 | 10,553 | Form 4 |
| 2025-03-05 | Waltermire Robert E.Senior VP, Chief Pharma Dev. | Option exercise M | +7,288 | 87.09 | 17,841 | Form 4 |
| 2025-03-05 | Waltermire Robert E.Senior VP, Chief Pharma Dev. | Grant or award A | +2,061 | – | 5,789 | Form 4 |
| 2025-03-05 | Dier MardiSVP and CFO | Grant or award A | +3,784 | – | 10,698 | Form 4 |
| 2025-03-05 | Sibold William JohnDirector, President and CEO | Grant or award A | +13,066 | – | 117,369 | Form 4 |
| 2025-02-27 | Bate KennethDirector | Option exercise M | +6,000 | 111.06 | 7,912 | Form 4 |
| 2025-02-27 | Bate KennethDirector | Option exercise M | +9,470 | 65.06 | 17,382 | Form 4 |
| 2025-02-27 | Bate KennethDirector | Option exercise M | +4,530 | 9.45 | 21,912 | Form 4 |
| 2025-02-27 | Daly James MDirector | Option exercise M | +9,470 | 65.06 | 11,382 | Form 4 |
| 2025-02-27 | Daly James MDirector | Option exercise M | +6,000 | 111.06 | 17,382 | Form 4 |
| 2025-02-27 | Sibold William JohnDirector, President and CEO | Option exercise M | +50,000 | – | 104,303 | Form 4 |
| 2024-11-07 | Levy Richard SDirector | Option exercise M | +5,000 | 7.36 | 16,012 | Form 4 |
| 2024-11-01 | Levy Richard SDirector | Option exercise M | +5,000 | 7.36 | 16,012 | Form 4 |
How to read it
- Buy, sale
- Code P and S on the form: shares bought or sold in the market, at the market price. The other codes are mostly pay (a grant, an option exercised) or tax (shares the company withheld), and say little about what the insider thinks of the price.
- Plan
- A sale or purchase under a Rule 10b5-1 plan, set up in advance and running on its own schedule. Since April 2023 the form has a box for it. Much executive selling is planned and says more about diversifying than about the company.
- Holds after
- The shares the insider still held after the trade, in the form the trade was in (directly, or indirectly through a trust or a fund).
- Value
- Shares times the price the form reports, which is often an average over several fills on the day.
Read from the SEC's own quarterly data sets of Forms 3, 4 and 5, and from each day's filings since the last one. A correcting amendment replaces the lines it restates. Every row links to its filing. None of this is advice: insiders sell for many reasons, and buy for fewer.